Beam Therapeutics to Present Data Across Hematology Franchise, Including First Clinical Data for BEAM-101 in Sickle Cell Disease and ESCAPE Non-human Primate Data, at American Society of Hematology (A
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- Wall St futures rise as Treasury yields cool, oil slips
- Oil slips as Mideast exports, G7 stockpile ease supply concerns
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
| Beam Inc. (NASDAQ: BEAM) | Delayed: 25.67 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.67 | 52 Week High | $83.60 | |||
| Open | $25.67 | 52 Week Low | $82.96 | |||
| Day High | $25.67 | P/E | 11.46 | |||
| Day Low | $25.67 | EPS | $2.24 | |||
| Volume | 29,952 | |||||
| Beam Inc. (NASDAQ: BEAM) | Delayed: 25.67 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.67 | 52 Week High | $83.60 | |||
| Open | $25.67 | 52 Week Low | $82.96 | |||
| Day High | $25.67 | P/E | 11.46 | |||
| Day Low | $25.67 | EPS | $2.24 | |||
| Volume | 29,952 | |||||
